SF3B1 mutated MDS: Blast count, genetic co-abnormalities and their impact on classification and prognosis

Recently, MDS with mutated SF3B1 and blast count <5% was proposed as distinct entity with favorable prognosis by the international working group for the prognosis of MDS (IWG-PM), the 5th edition of the WHO classification and the International Consensus Classification. To further characterize thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Sandra, Haferlach, Torsten, Meggendorfer, Manja, Hutter, Stephan, Hoermann, Gregor, Baer, Constance, Kern, Wolfgang, Haferlach, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712089/
https://www.ncbi.nlm.nih.gov/pubmed/36261576
http://dx.doi.org/10.1038/s41375-022-01728-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712089/
https://www.ncbi.nlm.nih.gov/pubmed/36261576
http://dx.doi.org/10.1038/s41375-022-01728-5

Ejemplares similares